Treatment with semaglutide improved maximum walking distance in patients with type 2 diabetes (T2D) and symptomatic peripheral artery disease (PAD), according to results from the STRIDE trial ...

Semaglutide may relieve peripheral arterial disease experienced by many patients with type 2 diabetes, a new Montreal study ...

A new international study has found that semaglutide, a medication commonly used to treat type 2 diabetes and obesity, ...

Semaglutide associated with increased walking distance in patients with symptomatic peripheral artery disease and type 2 diabetes.

Oral semaglutide demonstrated superior cardiometabolic outcomes relative to placebo and active comparators, including empaglifozin, in T2D.

Compounded semaglutide and Ozempic are different products. While both may be used in people with type 2 diabetes, Ozempic is approved by the FDA, but compounded semaglutide is not. Compounded ...

New research from the University of Sydney reveals that the number of Australians living with diabetes may be up to 35 percent higher than previously estimated.

Cassidy was an updates editor whose main responsibility is to write and edit articles on a range of home improvement topics ... or evaluations. A long-distance move shares many of the same ...

Walking is considered a great way to keep yourself physically active. Indian-American doctor Saurabh Sethi often shares health-related videos on his Instagram handle. Meanwhile, he has given ...

New research led by Western Sydney University finds limited evidence on the association between health literacy and medication adherence among ethnic minority adults living with Type 2 Diabetes.